Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

Vol. 8, Issue No. 8: SEPTEMBER 2009 - EXECUTIVE SUMMARY

Pharmaguy
Welcome to Volume 8, Issue #8 (SEPTEMBER 2009) of Pharma Marketing News. See the featured article summaries below.

John Mack, Publisher & Editor
editor@news.pharma-mkting.com
Let's Respond to FDA's Questions Regarding Its Regulation of Social Media
Upfront Commentary

Flying PigsWhatta ya know! Pigs can fly!

On Monday, September 21, 2009, the FDA published a notice in the Federal Register calling for a public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools.

I issued a petition calling upon the FDA to convene such a hearing back in April, 2009. At last my dream has come true!

The FDA is requesting the public to submit comments to a series of specific questions, which are included in a new survey created by Pharma Marketing Network/News. Let's use this survey to help educate the FDA on the issues.

Read this entire OpEd piece by John Mack here:
www.news.pharma-mkting.com/PMNews_88_UpFront.pdf

What If There Were No Rules in Pharma Marketing?
Be Sure Not to Cut Off the Ends of Your Ham

Ham"Sometimes the biggest inhibitor of the innovation process is ourselves," says author and blogger Jonathan Richman. Sometimes it's external forces (regulations, guidelines, naysayers). Still other times it's our interpretation of the external forces. This last one is perhaps the most menacing.

External forces include pesky things called laws that always seem to make it all a bit more complicated for pharmaceutical marketers. Like laws, rules and regulations, such as those from the FDA, often dictate what we can and can't do. Most of us know the rules and are forced to live under them.

What If There Were No Rules in Pharma Marketing? There's no FDA, no DDMAC, no FTC. Your company guidelines and rules don't exist and your regulatory and legal teams have been disbanded. It's a free-for-all and there are no rules. The question is: what would you do?

Topic headings include:
  • Ghost Rules
  • Poll Results
  • The Market Rules
  • Channels versus Communities
  • Rules or No Rules, Off-Label Comments Won't Fly
  • User-Generated Content
  • Ratings & Reviews
  • Do Your Patients Want Communities?
  • Enhanced Product Claims
  • Moderation Makes Sense
  • Marketing With Meaning
  • The FDA Isn't the Problem

Read this article now. It's FREE...

Download PDF file

Pharma-Sponsored Medical Ghostwriting
What the Ghosts Have to Say About It

Ghost WriterThe New York Times, Wall Street Journal, and the Journal of the American Medical Association, all recently have come out with stories and studies suggesting that pharma-sponsored medical ghostwriting is rampant. "These seemingly objective articles," says the WSJ, "which doctors around the world use to guide their care of patients, are often part of a marketing campaign by companies to promote a product or play up the condition it treats."

Pharma Marketing News surveyed readers to determine if medical journal articles sponsored and ghostwritten by drug companies are a legitimate part of marketing to physicians and to get opinions on various other issues raised in the press about ghostwriting.

One of the first things learned was that it is not easy to even define what is meant by "ghostwriting!"

This article presents results from the survey. Nearly 40% of the respondents were medical writers (including "ghosts") who made clear their opinions regarding the issue.

Topic headings include:
  • How Rampant is Pharma-Sponsored Ghostwriting?
  • Pharma's New Marketing Partner: Medical Journals
  • Defining Ghostwriting
  • Survey Results
  • Do Physicians Care?

Read this article now. It's FREE...

Download PDF file

Pharmaguy's Twitter Followers
What Do They Want and How Is It Relevant to You?

Followers of @pharmaguyNo matter what people say, your Twitter strategy must include building a large and qualified Twitter following. The last part - qualified - should be the most important part of your Twitter follower strategy. You want followers who are the right fit for your messages.

Pharmaguy (aka John Mack) now has over 3,500 followers and these followers are probably the same followers you'd like to have if and when you get involved in Twitter. But hurry! Breaking in as a power user may be difficult. Research shows a virtuous cycle may exist, making popular users ever more popular.

This article summarizes the findings of a survey of over 400 of @pharmaguy's followers. The results will give you a better idea why people who are interested in the pharmaceutical industry use Twitter and what they expect to get out of it.

Topic headings include:
  • Twitter is Important to Pharma
  • Does your company permit social media monitoring?
  • Who is Your Audience and What Do They Want?
  • What You Can Learn from My Survey Results
  • My Followers are Pharma Professionals
  • Why Do My Followers Use Twitter?
  • Why Do People Follow Me of Twitter?
  • Other Reasons for Using Twitter
  • How Useful are My Tweets?
  • What's In It For You?

Read this article now. It's FREE...

Download PDF file

Vol 8, #8 Contents







Contact Information
Editor
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.